Board Meeting Intimation for To Consider The Matter Of Conducting Annual General Meeting Of The Company
Citurgia Biochemicals Ltd operates in Commodity Chemicals within the Materials sector.
14 historical price candles were omitted because the exchange source has not been verified.
No red flags triggered.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Standalone figures
| Ratio | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Margins | |||
| Gross margin % | — | — | — |
| EBITDA margin % | — | — | — |
| EBIT margin % | — | — | — |
| PAT margin % | — | — | — |
| Working capital | |||
| Receivable days | — | — | — |
| Inventory days | — | — | — |
| Payable days | — | — | — |
| NWC days | — | — | — |
| Leverage | |||
| Current ratio | 0.92 | 0.91 | 0.87 |
| Debt to EBITDA | — | — | — |
| Debt to equity | -1.03 | -0.98 | -0.89 |
| Interest coverage | — | — | — |
| Asset turnover | 0 | 0 | 0 |
| Return ratios | |||
| Return on assets % | -4.3% | -3.9% | -7.1% |
| Return on capital employed % | -24.1% | -23.2% | -57.1% |
| Return on equity % | 7.3% | 6% | 9.6% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
No scheme among the 32 fund houses on record reported a position in Citurgia Biochemicals Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
Documents link to external sources (exchange filings, company investor pages).
Promoter holding up 0 percentage points since Sep 2025.
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Deepak Fertilizers And Petrochemicals Corporation LimitedDEEPAKFERTDEEPAKFERT | ₹16,417 Cr | ₹21,903 Cr | ₹12,104 Cr | ₹2,016 Cr | 14.6% | ₹984 Cr | 6.4% | 12.6% | 11.3% | 55 |
| Tata Chemicals LimitedTATACHEMTATACHEM | ₹15,487 Cr | ₹23,488 Cr | ₹15,120 Cr | ₹1,711 Cr | 12.4% | ₹-2,165 Cr | -11.8% | 2.9% | -8.9% | 113 |
| Gujarat Narmada Valley Fertilizers And Chemicals LimitedGNFCGNFC | ₹8,655 Cr | ₹8,655 Cr | ₹8,410 Cr | ₹1,241 Cr | 11.3% | ₹1,037 Cr | 10.4% | 10.6% | 9.1% | 81 |
| TANFAC Industries LtdTANFACINDTANFACIND | ₹6,909 Cr | ₹7,002 Cr | ₹711 Cr | ₹112 Cr | 15.8% | ₹70 Cr | 9.9% | 27.7% | 20.5% | 112 |
| Gujarat Alkalies And Chemicals LimitedGUJALKALIGUJALKALI | ₹4,430 Cr | ₹4,998 Cr | ₹4,498 Cr | ₹510 Cr | 9.3% | ₹66 Cr | -0.1% | 1.6% | -0% | 25 |
| Grauer & Weil India LimitedGRAUWEILGRAUWEIL | ₹3,709 Cr | ₹3,717 Cr | ₹1,134 Cr | ₹188 Cr | 16.6% | ₹69 Cr | 13.9% | 23% | 18% | 72 |
| Ghcl LimitedGHCLGHCL | ₹3,700 Cr | ₹3,762 Cr | ₹3,064 Cr | ₹689 Cr | 22.5% | ₹472 Cr | 15.4% | 17% | 13.4% | 126 |
| J.g.chemicals LimitedJGCHEMJGCHEM | ₹2,392 Cr | ₹2,399 Cr | ₹1,071 Cr | ₹96 Cr | 8.4% | ₹75 Cr | 7.1% | 18.2% | 13.3% | 101 |
| Thirumalai Chemicals LimitedTIRUMALCHMTIRUMALCHM | ₹1,764 Cr | ₹3,857 Cr | ₹1,832 Cr | ₹20 Cr | -2% | ₹-152 Cr | -9.7% | -3.3% | -12.3% | 14 |
| Ig Petrochemicals LimitedIGPLIGPL | ₹1,754 Cr | ₹2,110 Cr | ₹2,073 Cr | ₹207 Cr | 4.9% | ₹82 Cr | 0.1% | 3.2% | 0.2% | 23 |
| Indo Borax & Chemicals LimitedINDOBORAXINDOBORAX | ₹1,507 Cr | ₹1,507 Cr | ₹232 Cr | ₹52 Cr | 20.5% | ₹56 Cr | 23.3% | 15.5% | 15.1% | 110 |
| Innovassynth Technologies (India) LtdINOVSYNTHINOVSYNTH | ₹1,462 Cr | ₹1,466 Cr | ₹0 Cr | ₹-0 Cr | — | ₹-5 Cr | — | -1.1% | -12% | — |
Board Meeting Intimation for To Consider The Matter Of Conducting Annual General Meeting Of The Company
Closure of Trading Window
Registrar Of Companies, Mumbai ('ROC'), Approval For Extension Of 51ST Annual General Meeting
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
| Date | Category | Subject | Filing |
|---|---|---|---|
| 1 Oct 2026, 5:05 pm | Board Meeting | Board Meeting Intimation for To Consider The Matter Of Conducting Annual General Meeting Of The Company | |
| 30 Sept 2026, 1:30 pm | Insider Trading / SAST Closure of Trading Window | Closure of Trading Window |
| 18 Sept 2026, 4:44 pm | Others | Registrar Of Companies, Mumbai ('ROC'), Approval For Extension Of 51ST Annual General Meeting |
| 8 Sept 2026, 4:42 pm | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 8 Sept 2026, 3:39 pm | Company Update Resignation of Company Secretary / Compliance Officer | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer |
| ₹ Cr | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| 0 | 0 | 1 | |
| -0 | -0 | -1 | |
| OPM % | — | — | — |
| Depreciation | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 |
| 0 | 0 | 0 | |
| Profit before tax | -0 | -0 | -1 |
| Tax | 0 | 0 | 0 |
| PAT | -0 | -0 | -1 |
| PAT margin % | — | — | — |
| EPS (₹) | -0 | -0 | 0 |
| EPS adjusted (₹) | -0 | -0 | -0.1 |
| Annual report | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity capital | 26 | 26 | 26 |
| Reserves | -33 | -33 | -34 |
| 7 | 7 | 7 | |
| 11 | 11 | 11 | |
| Total equity & liabilities | 11 | 11 | 10 |
| 1 | 1 | 0 | |
| CWIP | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| 10 | 10 | 10 | |
| Total assets | 11 | 11 | 10 |
| ₹ Cr | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| -0 | -0 | -0 | |
| -0 | 0 | 0 | |
| 0 | 0 | 0 | |
| Net cash flow | 0 | 0 | 0 |
| Free cash flow | -0 | -0 | -0 |
| CFO / Operating profit % | — | — | — |